Handelen AngioDynamics, Inc. - ANGO CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.12 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
AngioDynamics Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 9.33 |
| Open* | 9.35 |
| 1-Jaarlijkse Verandering* | -51.1% |
| Dagelijks bereik* | 9.2 - 9.49 |
| 52 wekelijks bereik | 8.18-24.74 |
| Weekgemiddelde volume (10 dagen) | 262.16K |
| Gemiddeld volume (3 maanden) | 7.26M |
| Marktkapitalisatie | 364.51M |
| P/E Ratio | -100.00K |
| Uitstaande Aandelen | 39.24M |
| Omzet | 334.68M |
| EPS | -0.95 |
| Dividend (opbrengst %) | N/A |
| Beta | 0.59 |
| Volgende inkomsten datum | Jul 10, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| May 26, 2023 | 9.20 | 0.13 | 1.43% | 9.07 | 9.55 | 9.02 |
| May 25, 2023 | 9.33 | 0.01 | 0.11% | 9.32 | 9.43 | 9.04 |
| May 24, 2023 | 9.60 | 0.10 | 1.05% | 9.50 | 9.82 | 9.40 |
| May 23, 2023 | 9.66 | 0.09 | 0.94% | 9.57 | 9.86 | 9.42 |
| May 22, 2023 | 9.58 | 0.13 | 1.38% | 9.45 | 9.72 | 9.33 |
| May 19, 2023 | 9.57 | 0.31 | 3.35% | 9.26 | 9.79 | 9.26 |
| May 18, 2023 | 9.55 | 0.30 | 3.24% | 9.25 | 9.62 | 9.14 |
| May 17, 2023 | 9.52 | 0.22 | 2.37% | 9.30 | 9.65 | 9.19 |
| May 16, 2023 | 9.37 | 0.24 | 2.63% | 9.13 | 9.42 | 9.10 |
| May 15, 2023 | 9.28 | 0.15 | 1.64% | 9.13 | 9.37 | 8.99 |
| May 12, 2023 | 9.27 | 0.29 | 3.23% | 8.98 | 9.32 | 8.92 |
| May 11, 2023 | 9.16 | 0.21 | 2.35% | 8.95 | 9.40 | 8.85 |
| May 10, 2023 | 9.07 | 0.27 | 3.07% | 8.80 | 9.16 | 8.73 |
| May 9, 2023 | 8.92 | 0.17 | 1.94% | 8.75 | 9.21 | 8.67 |
| May 8, 2023 | 8.90 | 0.22 | 2.53% | 8.68 | 8.95 | 8.51 |
| May 5, 2023 | 8.66 | 0.30 | 3.59% | 8.36 | 8.75 | 8.30 |
| May 4, 2023 | 8.42 | 0.02 | 0.24% | 8.40 | 8.59 | 8.32 |
| May 3, 2023 | 8.60 | 0.39 | 4.75% | 8.21 | 8.84 | 8.21 |
| May 2, 2023 | 8.45 | 0.24 | 2.92% | 8.21 | 8.65 | 8.18 |
| May 1, 2023 | 8.53 | 0.31 | 3.77% | 8.22 | 8.60 | 8.11 |
AngioDynamics, Inc. Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| Monday, July 10, 2023 | ||
| Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q4 2023 AngioDynamics Inc Earnings Release Q4 2023 AngioDynamics Inc Earnings ReleaseForecast -Previous - |
| Wednesday, October 4, 2023 | ||
| Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q1 2024 AngioDynamics Inc Earnings Release Q1 2024 AngioDynamics Inc Earnings ReleaseForecast -Previous - |
| Friday, November 3, 2023 | ||
| Tijd (UTC) (UTC) 16:00 | Land US
| Evenement AngioDynamics Inc Annual Shareholders Meeting AngioDynamics Inc Annual Shareholders MeetingForecast -Previous - |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale inkomsten | 316.219 | 291.01 | 264.157 | 270.634 | 261.655 |
| Inkomsten | 316.219 | 291.01 | 264.157 | 270.634 | 261.655 |
| Kosten van opbrengsten, totaal | 150.487 | 134.222 | 113.885 | 114.634 | 117.799 |
| Brutowinst | 165.732 | 156.788 | 150.272 | 156 | 143.856 |
| Totale bedrijfskosten | 344.69 | 326.293 | 431.255 | 280.03 | 275.825 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 133.752 | 117.224 | 116.506 | 111.731 | 104.1 |
| Onderzoek & Ontwikkeling | 30.739 | 36.39 | 29.682 | 28.258 | 24.338 |
| Depreciation / Amortization | 19.458 | 18.136 | 18.121 | 17.056 | 13.906 |
| Ongebruikelijke uitgaven (inkomsten) | 9.042 | 20.232 | 164.592 | 15.127 | 15.432 |
| Other Operating Expenses, Total | 1.212 | 0.089 | -11.531 | -6.776 | 0.25 |
| Bedrijfsresultaat | -28.471 | -35.283 | -167.098 | -9.396 | -14.17 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -0.688 | -0.861 | -0.907 | -5.099 | -3.062 |
| Overige, Netto | -0.79 | 0.092 | -0.13 | -0.207 | -0.031 |
| Netto inkomen voor belastingen | -29.949 | -36.052 | -168.135 | -14.702 | -17.263 |
| Netto inkomen na belastingen | -26.547 | -31.548 | -166.787 | -11.146 | -13.627 |
| Netto inkomen voor extra. Posten | -26.547 | -31.548 | -166.787 | -11.146 | -13.627 |
| Totale buitengewone posten | 0 | 0 | 72.486 | 29.962 | |
| Netto inkomen | -26.547 | -31.548 | -166.787 | 61.34 | 16.335 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -26.547 | -31.548 | -166.787 | -11.146 | -13.627 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -26.547 | -31.548 | -166.787 | 61.34 | 16.335 |
| Verwaterd Netto Inkomen | -26.547 | -31.548 | -166.787 | 61.34 | 16.335 |
| Verwaterd Gewogen Gemiddelde Aandelen | 39.009 | 38.342 | 37.961 | 37.485 | 37.075 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.68054 | -0.82281 | -4.39364 | -0.29735 | -0.36755 |
| Verwaterde Genormaliseerde Winst per Aandeel | -0.52987 | -0.47982 | -1.57536 | -0.03504 | -0.097 |
| Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 80.712 | 85.429 | 81.537 | 86.998 | 73.97 |
| Inkomsten | 80.712 | 85.429 | 81.537 | 86.998 | 73.97 |
| Kosten van opbrengsten, totaal | 40.208 | 40.351 | 39.232 | 40.543 | 35.387 |
| Brutowinst | 40.504 | 45.078 | 42.305 | 46.455 | 38.583 |
| Totale bedrijfskosten | 89.64 | 93.544 | 94.838 | 93.395 | 79.265 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 34.245 | 36.842 | 36.644 | 37.936 | 29.143 |
| Onderzoek & Ontwikkeling | 6.852 | 6.838 | 8.333 | 7.866 | 7.28 |
| Depreciation / Amortization | 4.739 | 4.808 | 4.837 | 4.853 | 4.895 |
| Ongebruikelijke uitgaven (inkomsten) | 3.369 | 3.059 | 5.581 | 1.99 | 2.359 |
| Other Operating Expenses, Total | 0.227 | 1.646 | 0.211 | 0.207 | 0.201 |
| Bedrijfsresultaat | -8.928 | -8.115 | -13.301 | -6.397 | -5.295 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -0.736 | -0.684 | -0.381 | -0.185 | -0.173 |
| Overige, Netto | 0 | -0.252 | -0.175 | -0.139 | -0.289 |
| Netto inkomen voor belastingen | -9.664 | -9.051 | -13.857 | -6.721 | -5.757 |
| Netto inkomen na belastingen | -9.485 | -8.486 | -13.004 | -6.266 | -4.958 |
| Netto inkomen voor extra. Posten | -9.485 | -8.486 | -13.004 | -6.266 | -4.958 |
| Netto inkomen | -9.485 | -8.486 | -13.004 | -6.266 | -4.958 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -9.485 | -8.486 | -13.004 | -6.266 | -4.958 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -9.485 | -8.486 | -13.004 | -6.266 | -4.958 |
| Verwaterd Netto Inkomen | -9.485 | -8.486 | -13.004 | -6.266 | -4.958 |
| Verwaterd Gewogen Gemiddelde Aandelen | 39.509 | 39.49 | 39.302 | 39.159 | 39.092 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.24007 | -0.21489 | -0.33087 | -0.16001 | -0.12683 |
| Verwaterde Genormaliseerde Winst per Aandeel | -0.18465 | -0.16454 | -0.23857 | -0.12698 | -0.0876 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 143.345 | 140.879 | 152.913 | 315.292 | 168.032 |
| Geldmiddelen en kortetermijnbeleggingen | 30.931 | 50.956 | 54.435 | 227.641 | 75.413 |
| Geldmiddelen & Equivalenten | 28.825 | 48.161 | 54.435 | 227.641 | 74.096 |
| Korte Termijn Investeringen | 2.106 | 2.795 | 0 | 1.317 | |
| Totale Vorderingen, Netto | 52.304 | 35.407 | 34.174 | 43.577 | 39.401 |
| Accounts Receivable - Trade, Net | 52.304 | 35.405 | 31.263 | 43.577 | 39.401 |
| Total Inventory | 51.392 | 48.614 | 59.905 | 40.071 | 48.916 |
| Prepaid Expenses | 4.524 | 3.991 | 4.399 | 4.003 | 4.302 |
| Other Current Assets, Total | 4.194 | 1.911 | 0 | ||
| Total Assets | 552.751 | 561.438 | 594.214 | 836.438 | 705.472 |
| Property/Plant/Equipment, Total - Net | 51.979 | 46.455 | 38.458 | 24.258 | 42.461 |
| Property/Plant/Equipment, Total - Gross | 103.048 | 92.09 | 79.119 | 65.866 | 65.59 |
| Accumulated Depreciation, Total | -51.069 | -45.635 | -40.661 | -41.608 | -48.794 |
| Goodwill, Net | 201.058 | 201.316 | 200.515 | 347.666 | 361.252 |
| Intangibles, Net | 152.38 | 168.977 | 197.136 | 145.387 | 130.31 |
| Other Long Term Assets, Total | 3.989 | 3.811 | 5.192 | 3.835 | 3.417 |
| Total Current Liabilities | 74.324 | 57.584 | 51.445 | 73.302 | 57.301 |
| Accounts Payable | 28.047 | 19.63 | 19.096 | 22.829 | 15.775 |
| Accrued Expenses | 37.402 | 37.874 | 31.457 | 38.338 | 34.426 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 7.5 | 5 | ||
| Other Current Liabilities, Total | 8.875 | 0.08 | 0.892 | 4.635 | 2.1 |
| Total Liabilities | 128.262 | 121.981 | 139.342 | 221.623 | 162.877 |
| Total Long Term Debt | 25 | 20 | 40 | 124.407 | 86.621 |
| Long Term Debt | 25 | 20 | 40 | 124.407 | 86.621 |
| Deferred Income Tax | 16.037 | 19.955 | 24.057 | 14.542 | 17.173 |
| Other Liabilities, Total | 12.901 | 24.442 | 23.84 | 9.372 | 1.782 |
| Total Equity | 424.489 | 439.457 | 454.872 | 614.815 | 542.595 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.38 | 0.377 | 0.374 | 0.372 | 0.37 |
| Additional Paid-In Capital | 586.879 | 573.507 | 561.871 | 555.04 | 543.762 |
| Retained Earnings (Accumulated Deficit) | -158.413 | -131.866 | -100.318 | 66.469 | 5.129 |
| Treasury Stock - Common | -5.714 | -5.714 | -5.714 | -5.714 | -5.714 |
| Other Equity, Total | 1.357 | 3.153 | -1.341 | -1.352 | 0.083 |
| Total Liabilities & Shareholders’ Equity | 552.751 | 561.438 | 594.214 | 836.438 | 705.472 |
| Total Common Shares Outstanding | 39.1712 | 38.5509 | 38.0785 | 37.6144 | 37.2245 |
| Unrealized Gain (Loss) | 0 | 0 | -1.035 |
| Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 152.574 | 158.83 | 151.371 | 143.345 | 127.686 |
| Geldmiddelen en kortetermijnbeleggingen | 30.111 | 29.857 | 24.564 | 28.825 | 23.89 |
| Geldmiddelen & Equivalenten | 30.111 | 29.857 | 24.564 | 28.825 | 23.89 |
| Totale Vorderingen, Netto | 50.892 | 52.852 | 53.586 | 52.304 | 41.81 |
| Accounts Receivable - Trade, Net | 50.892 | 52.852 | 53.586 | 52.304 | 41.81 |
| Total Inventory | 63.532 | 63.177 | 57.609 | 51.392 | 48.039 |
| Prepaid Expenses | 8.039 | 12.944 | 15.612 | 10.824 | 13.947 |
| Total Assets | 542.849 | 558.207 | 557.652 | 552.751 | 543.178 |
| Property/Plant/Equipment, Total - Net | 50.702 | 51.705 | 52.524 | 51.979 | 51.188 |
| Goodwill, Net | 199.976 | 200.755 | 201.038 | 201.058 | 201.484 |
| Intangibles, Net | 134.011 | 141.943 | 147.976 | 152.38 | 159.105 |
| Other Long Term Assets, Total | 5.586 | 4.974 | 4.743 | 3.989 | 3.715 |
| Total Current Liabilities | 69.632 | 73.567 | 66.39 | 74.324 | 49.368 |
| Accounts Payable | 35.6 | 34.688 | 29.258 | 28.047 | 21.57 |
| Accrued Expenses | 24.074 | 29.024 | 28.146 | 37.402 | 27.722 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | |||||
| Other Current Liabilities, Total | 9.958 | 9.855 | 8.986 | 8.875 | 0.076 |
| Total Liabilities | 145.194 | 150.249 | 143.611 | 128.262 | 113.486 |
| Total Long Term Debt | 49.807 | 49.796 | 49.798 | 25 | 25 |
| Long Term Debt | 49.807 | 49.796 | 49.798 | 25 | 25 |
| Deferred Income Tax | 13.49 | 14.29 | 15.115 | 16.037 | 16.961 |
| Other Liabilities, Total | 12.265 | 12.596 | 12.308 | 12.901 | 22.157 |
| Total Equity | 397.655 | 407.958 | 414.041 | 424.489 | 429.692 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.382 | 0.381 | 0.381 | 0.38 | 0.38 |
| Additional Paid-In Capital | 596.225 | 593.482 | 589.984 | 586.879 | 583.647 |
| Retained Earnings (Accumulated Deficit) | -189.388 | -179.903 | -171.417 | -158.413 | -152.147 |
| Treasury Stock - Common | -5.714 | -5.714 | -5.714 | -5.714 | -5.714 |
| Other Equity, Total | -3.85 | -0.288 | 0.807 | 1.357 | 3.526 |
| Total Liabilities & Shareholders’ Equity | 542.849 | 558.207 | 557.652 | 552.751 | 543.178 |
| Total Common Shares Outstanding | 39.6064 | 39.5041 | 39.4777 | 39.1712 | 39.1501 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | -26.547 | -31.548 | -166.787 | 61.34 | 16.335 |
| Geldmiddelen uit Operationele Activiteiten | -7.194 | 24.093 | -14.554 | 37.44 | 41.287 |
| Geldmiddelen uit Operationele Activiteiten | 29.349 | 25.916 | 23.805 | 25.88 | 23.163 |
| Deferred Taxes | -3.708 | -4.805 | -1.568 | -2.655 | -8.947 |
| Niet-Geldelijke Posten | 14.759 | 25.458 | 158.545 | -45.861 | 8.276 |
| Cash Taxes Paid | 0.329 | 0.313 | 0.682 | 0.426 | 0.036 |
| Contant Betaalde Rente | 0.562 | 0.731 | 0.413 | 5.115 | 3.19 |
| Veranderingen in het Operationeel Kapitaal | -21.047 | 9.072 | -28.549 | -1.264 | 2.46 |
| Geldmiddelen uit Investeringsactiviteiten | -19.307 | -13.711 | -63.345 | 82.554 | -3.656 |
| Kapitaaluitgaven | -4.297 | -5.187 | -7.585 | -3.118 | -3.656 |
| Overige Cash Flow investeringsposten, Totaal | -15.01 | -8.524 | -55.76 | 85.672 | 0 |
| Geldmiddelen uit Financieringsactiviteiten | 7.683 | -16.986 | -95.242 | 33.931 | -11.551 |
| Financiering van Cash Flow Posten | 0 | 0 | -1.983 | -8.1 | -9.5 |
| Uitgifte (Aflossing) van aandelen, netto | 2.683 | 3.014 | -0.759 | 2.031 | 2.949 |
| Uitgifte (Aflossing) van Schulden, Netto | 5 | -20 | -92.5 | 40 | -5 |
| Wisselkoerseffecten | -0.518 | 0.33 | -0.065 | -0.38 | 0.472 |
| Nettowijziging in Geldmiddelen | -19.336 | -6.274 | -173.206 | 153.545 | 26.552 |
| Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -30.975 | -21.49 | -13.004 | -26.547 | -20.281 |
| Cash From Operating Activities | -15.876 | -17.246 | -24.745 | -7.194 | -15.754 |
| Cash From Operating Activities | 23.316 | 15.478 | 7.66 | 29.349 | 21.682 |
| Deferred Taxes | -1.752 | -1.525 | -0.907 | -3.708 | -3.121 |
| Non-Cash Items | 12.531 | 9.915 | 3.892 | 14.759 | 10.768 |
| Changes in Working Capital | -18.996 | -19.624 | -22.386 | -21.047 | -24.802 |
| Cash From Investing Activities | -8.218 | -6.072 | -3.576 | -19.307 | -15.534 |
| Capital Expenditures | -3.296 | -2.63 | -1.349 | -4.297 | -3.258 |
| Other Investing Cash Flow Items, Total | -4.922 | -3.442 | -2.227 | -15.01 | -12.276 |
| Cash From Financing Activities | 25.42 | 24.479 | 24.376 | 7.683 | 7.354 |
| Financing Cash Flow Items | -0.751 | -0.751 | -0.706 | 0 | |
| Issuance (Retirement) of Stock, Net | 1.171 | 0.23 | 0.082 | 2.683 | 2.354 |
| Issuance (Retirement) of Debt, Net | 25 | 25 | 25 | 5 | 5 |
| Foreign Exchange Effects | -0.04 | -0.129 | -0.316 | -0.518 | -0.337 |
| Net Change in Cash | 1.286 | 1.032 | -4.261 | -19.336 | -24.271 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 16.42 | 6442622 | 137748 | 2023-03-31 | LOW |
| Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 9.8574 | 3867708 | -393766 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.0089 | 2750029 | -26122 | 2023-03-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 6.3302 | 2483746 | -203735 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.2873 | 2074556 | 64844 | 2023-03-31 | LOW |
| Systematic Financial Management, L.P. | Investment Advisor | 3.5811 | 1405089 | 132928 | 2023-03-31 | LOW |
| Millennium Management LLC | Hedge Fund | 3.0095 | 1180811 | -772194 | 2023-03-31 | HIGH |
| Clemmer James C | Individual Investor | 2.3555 | 924211 | 10000 | 2022-10-10 | |
| Manulife Investment Management (North America) Limited | Investment Advisor | 2.316 | 908697 | 32162 | 2023-03-31 | LOW |
| Paradigm Capital Management, Inc. | Investment Advisor/Hedge Fund | 2.2171 | 869900 | 512400 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9153 | 751491 | 36496 | 2023-03-31 | LOW |
| Assenagon Asset Management S.A. | Investment Advisor | 1.7191 | 674506 | 529145 | 2023-03-31 | HIGH |
| Heartland Advisors, Inc. | Investment Advisor/Hedge Fund | 1.5947 | 625716 | 13994 | 2023-03-31 | |
| Segall Bryant & Hamill, LLC | Investment Advisor/Hedge Fund | 1.5643 | 613787 | 132146 | 2023-03-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.2339 | 484137 | -51548 | 2023-03-31 | HIGH |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.2146 | 476566 | 370301 | 2023-03-31 | LOW |
| Tamarack Advisers, LP | Hedge Fund | 1.2106 | 475000 | -15000 | 2023-03-31 | |
| Nuveen LLC | Pension Fund | 1.0929 | 428815 | 111340 | 2023-03-31 | LOW |
| Citadel Advisors LLC | Hedge Fund | 1.0744 | 421566 | 5907 | 2023-03-31 | HIGH |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9968 | 391100 | 391100 | 2022-12-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group530K+
Handelaren
87K+
Actieve klanten per maand
$46M+
Maandelijks beleggingsvolume
$31M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
AngioDynamics, Inc. Company profile
Over AngioDynamics, Inc.
AngioDynamics, Inc. ontwerpt, vervaardigt en verkoopt een reeks medische, chirurgische en diagnostische hulpmiddelen die door professionele zorgverleners worden gebruikt voor de behandeling van perifere vasculaire aandoeningen, vasculaire toegang en voor gebruik in de oncologie en chirurgische omgevingen. De hulpmiddelen worden gebruikt bij minimaal invasieve, beeldgestuurde procedures. Het productaanbod omvat endovasculaire therapieën, oncologie/chirurgie (OS) en vasculaire toegang (VA). Het productaanbod op het gebied van endovasculaire therapieën ondersteunt de medische gebieden trombusbeheer, aterectomie, perifere producten (kern) en veneuze insufficiëntie. Het aanbod van OS-producten omvat een reeks ablatietechnologieën, waaronder thermische weefselablatiesystemen, chirurgische resectie en de Irreversible Electroporation (IRE)-technologie, het NanoKnife System. Zijn portefeuille van VA-producten omvat perifeer ingebrachte centrale katheters (PICC's), midline katheters, implanteerbare poorten, dialysekatheters en verwante accessoires en benodigdheden.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
14 Plaza Dr
LATHAM
NEW YORK 12110
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 530.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen